At Joseph Eye & Laser Center, we know patients undergoing cataract surgery today want a replacement lens that delivers the vision they need to live full, active lives without always being dependent on glasses. We are excited to announce revolutionary technology that has just become available! Joseph Eye & Laser Center is the first practice in Northwestern Pennsylvania to offer this new technology. Before the release of this new intraocular lens (IOL) technology, patients had to compromise on the vision they would have after cataract surgery. Choosing to have good distance vision, near vision, or intermediate distance, but never being able to have all three. Now having perfect vision at near, intermediate, and distance is possible for the first time with PanOptix, the first Trifocal IOL ever in the U.S.!
PanOptix is an excellent lens option to address these needs and is clinically proven to deliver an outstanding range of vision. PanOptix has been available for the past 3 years in Europe and Canada, and has an excellent safety record and excellent results, with 99% of patients saying that they would choose the PanOptix again. Our goal is to ensure optimal outcomes for cataract patients looking to correct their vision at all distances, with the vast majority of them never needing to wear glasses post-surgery. We can now achieve these results without compromise.
Dr. Christopher Joseph, DO, FACS, is the first surgeon in Northwestern Pennsylvania to implant the PanOptix Trifocal IOL into a patient’s eye and one of the first to implant a PanOptix in the United States. Dr. Joseph is an expert in cataract surgery and refractive surgery. He completed an extra year of training by pursuing a fellowship in Pittsburgh, PA, which specialized in Laser Cataract Surgery and High-Tech lens Implants (IOLs), used to correct your vision during cataract surgery. Dr. Joseph is also one of the few Ophthalmologist in the United States recognized for his excellence by the America College of Surgeons (ACS). In 2018, the ACS nominated Dr. Joseph as a Fellow of the American College of Surgeons (FACS).
Alcon, the global leader in eye care, recently announced the Food and Drug Administration (FDA) approval and its initial commercial launch of AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL), the first and only trifocal lens for U.S. patients undergoing cataract surgery. PanOptix is clinically shown to deliver an exceptional combination of near, intermediate, and distance vision while significantly reducing the need for glasses after surgery.
PanOptix is already one of the leading presbyopia-correcting IOLs in more than 70 countries. It is designed for today’s active lifestyles, from viewing mobile devices and computer screens to high-quality distance vision in a range of lighting conditions. The new lens uses ENLIGHTEN® Optical Technology, a proprietary design that optimizes intermediate vision without compromising near and distance vision. PanOptix patients demonstrated exceptional, uninterrupted vision. The results also showed high patient satisfaction with more than ninety-nine percent of PanOptix patients saying they would choose the same lens again.
A cataract is a cloudy area in the natural lens of the eye that affects vision. As a cataract develops, the eye’s lens gradually becomes hard and cloudy allowing less light to pass through, which makes it more difficult to see. The vast majority of cataracts result from normal aging, but radiation exposure, taking steroids, diabetes, and eye trauma can accelerate their development. Cataracts are the most common age-related eye condition and the leading cause of preventable blindness. Twenty million people in the U.S. age 40 and older have cataracts.5 Cataracts are treated by removing the eye’s cloudy natural lens and surgically replacing it with an intraocular lens or IOL. More than 98 percent of cataract surgeries are considered successful, and patients typically can return to their normal routines within 24 hours.
Presbyopia is a common, age-related vision condition in which people have difficulty focusing on things up close. It involves the gradual loss of the eye’s ability to focus on close objects, such as smartphones, computers, books, and menus.8 Almost everyone will experience presbyopia to some degree as they age, with symptoms often first appearing as an individual enters their 40’s and continues to worsen into their 60’s. In the U.S., an estimated 112 million people experience vision issues due to presbyopia – a number that’s expected to continue increasing. The condition is not a disease, so it cannot be cured; however, there are safe and effective ways to correct presbyopia, including eyeglasses, contact lenses, or refractive surgery.
Choosing the Right Surgeon
The use of cutting-edge technology can be difficult to master, so picking the right surgeon is critical. Dr. Joseph is Fellowship-trained in laser cataract surgery, dropless cataract surgery, high-tech lens implants (IOLs), and minimally invasive glaucoma surgery (MIGS). If you would like to further learn about any of our cataract surgery procedures, contact the trusted experts at Joseph Eye & Laser Center today.